original ) (raw )A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
Kevin Liu
Pharmaceutical Research, 2006
View PDFchevron_right
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
nayab tahir
International Journal of Nanomedicine, 2019
View PDFchevron_right
Smart Lipid–Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells
Vittoria Rago
International Journal of Molecular Sciences, 2022
View PDFchevron_right
Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with Doxorubicin
Svetlana Gelperina
2021
View PDFchevron_right
Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistance
Ralf Morgenstern
Biomaterials, 2014
View PDFchevron_right
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
zar chi soe
Pharmaceutics, 2019
View PDFchevron_right
Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells
Amoura Abou-El-Naga
International Journal of Nanomedicine, 2018
View PDFchevron_right
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative
Chiara Dianzani
Nanomaterials, 2018
View PDFchevron_right
Doxorubicin-loaded polymeric nanoparticles containing ketoester-based block and cholesterol moiety as specific vehicles to fight estrogen-dependent breast cancer
Paweł Misiak
Cancer Nanotechnology
View PDFchevron_right
New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles
Samuel Mussi
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013
View PDFchevron_right
Self‐Assembly of Cholesterol‐Doxorubicin and TPGS into Prodrug‐Based Nanoparticles with Enhanced Cellular Uptake and Lysosome‐Dependent Pathway in Breast Cancer Cells
Filipe Olim
European Journal of Lipid Science and Technology, 2021
View PDFchevron_right
The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin
Afsaneh Lavasanifar , xiaobing xiong
Biomaterials, 2010
View PDFchevron_right
A Comparative Study of Cellular Uptake and Subcellular Localization of Doxorubicin Loaded in Self-Assemblies of Amphiphilic Copolymers with Pendant Dendron by MDA-MB-231 Human Breast Cancer Cells
Geetha Viswanathan
Macromolecular bioscience, 2016
View PDFchevron_right
Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy
Lucas Ferreira
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016
View PDFchevron_right
Formulation development of lipid polymer hybrid nanoparticles of doxorubicin and its in-vitro, in-vivo and computational evaluation
Maqsood Rehman
Frontiers in Pharmacology
View PDFchevron_right
Synergistic Therapeutic Strategy of Dual Drug-loaded Lipid Polymer Hybrid Nanoparticles for Breast Cancer Treatment
Duy Hieu Truong
2019
View PDFchevron_right
Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES)
Yong-Yu Liu
International journal of pharmaceutics, 2012
View PDFchevron_right
Evaluation of bioavailability, efficacy, and safety profile of doxorubicin-loaded solid lipid nanoparticles
sarasija suresh
Journal of Nanoparticle Research, 2013
View PDFchevron_right
Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle
Joo-Youp Lee
International Journal of Pharmaceutics, 2017
View PDFchevron_right
Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
Alan Alfieri
Precision Nanomedicine
View PDFchevron_right
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
Adam Shuhendler
Breast Cancer Research and Treatment, 2010
View PDFchevron_right
Redox-Sensitive Nanoparticles from Amphiphilic Cholesterol-Based Block Copolymers for Enhanced Tumor Intracellular Release of Doxorubicin
Mansoor Amiji
Nanomedicine: Nanotechnology, Biology and Medicine, 2015
View PDFchevron_right
Improved pharmacokinetics and enhanced tumor growth inhibition using a nanostructured lipid carrier loaded with doxorubicin and modified with a layer-by-layer polyelectrolyte coating
Gaurav Parekh
View PDFchevron_right
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies
Elena Peira
Journal of microencapsulation, 2016
View PDFchevron_right
Augmented Anticancer Efficacy of Doxorubicin-Loaded Polymeric Nanoparticles after Oral Administration in a Breast Cancer Induced Animal Model
ramarao poduri
Molecular Pharmaceutics, 2011
View PDFchevron_right